Related Experiment Video
Updated: May 19, 2026
11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
MicroRNA-mediated gene regulations in human sarcomas
Subbaya Subramanian1, Reena V Kartha
1Department of Surgery, University of Minnesota, 11-212 Moos Tower (Mail Code: MMC 195), 515 Delaware St, S.E, Minneapolis, MN 55455, USA. subree@umn.edu
Cellular and Molecular Life Sciences : CMLS
|August 28, 2012
Summary
MicroRNAs (miRNAs) are small RNAs involved in sarcoma development. Understanding miRNA-gene networks offers new avenues for sarcoma prevention, diagnosis, and treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Sarcomas are diverse mesenchymal tumors with poor prognoses for aggressive subtypes.
- Current treatments face challenges with effectiveness and drug resistance.
- Understanding sarcoma pathobiology is crucial for developing novel therapeutics.
Purpose of the Study:
- To review the current knowledge of microRNA (miRNA)-gene regulatory networks in various sarcoma types.
- To explore the role of deregulated miRNA expression in sarcoma pathobiology.
- To provide a perspective on miRNA-mediated gene regulation in sarcomas.
Main Methods:
- Literature review of studies on miRNA expression and function in sarcomas.
- Analysis of miRNA-gene interactions and regulatory networks.
- Discussion of conserved and shared miRNA-gene networks across sarcoma subtypes.
Main Results:
- MicroRNAs are frequently deregulated in sarcomas and play significant roles in their development.
- Specific miRNA-gene regulatory networks are implicated in the pathobiology of different sarcoma types.
- Shared and conserved miRNA-gene networks may offer common therapeutic targets.
Conclusions:
- MicroRNAs are critical regulators in sarcoma pathobiology.
- Comprehensive understanding of miRNA-gene networks is essential for advancing sarcoma treatment.
- Targeting miRNA-gene interactions presents a promising strategy for sarcoma prevention, diagnosis, and therapy.
Related Concept Videos
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...